{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Leea indica", "Methyl gallate", "NK cell", "Ovarian cancer", "Oxaliplatin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36899361", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "11"}], "Language": ["eng"], "ELocationID": ["79", "10.1186/s12906-023-03904-1"], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "23", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "11"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "Effects of Leea indica leaf extracts and its phytoconstituents on natural killer cell-mediated cytotoxicity in human ovarian cancer.", "Pagination": {"StartPage": "79", "MedlinePgn": "79"}, "Abstract": {"AbstractText": ["The rich biodiversity of medicinal plants and their importance as sources of novel therapeutics and lead compounds warrant further research. Despite advances in debulking surgery and chemotherapy, the risks of recurrence of ovarian cancer and resistance to therapy are\u00a0significant and the clinical outcomes of ovarian cancer remain poor or even incurable.", "This study aims to investigate the effects of leaf extracts from a medicinal plant Leea indica and its selected phytoconstituents on human ovarian cancer cells and in combination with oxaliplatin and natural killer (NK) cells.", "Fresh, healthy leaves of L. indica were harvested and extracted\u00a0in 70% methanol\u00a0by maceration. The crude extract was partitioned with n-hexane, dichloromethane and ethyl acetate. Selected extracts and compounds were analyzed for their effects on cell viability of\u00a0human ovarian cancer cells, NK cell cytotoxicity, and stress ligands expression for NK cell receptors. They were also evaluated for their effects on TNF-\u03b1 and IL-1\u03b2 production by enzyme-linked immunosorbent assay in lipopolysaccharide-stimulated human U937 macrophages.", "Leaf extracts of L. indica increased the susceptibility of human ovarian tumor cells to NK cell-mediated cytotoxicity. Treatment of cancer cells with methyl gallate but not gallic acid upregulated the expression of stress ligands. Tumor cells pretreated with combination of methyl gallate and low concentration of oxaliplatin displayed increased levels of stress ligands expression and concomitantly enhanced susceptibility to NK cell-mediated cytolysis. Further, NK cells completely abrogated the growth of methyl gallate-pretreated ovarian cancer cells. The leaf extracts suppressed TNF-\u03b1 and IL-1\u03b2 production in human U937 macrophages. Methyl gallate was more potent than gallic acid in down-regulating these cytokine levels.", "We demonstrated for the first time that leaf extracts of L. indica and its phytoconstituent methyl gallate enhanced the susceptibility of ovarian tumor cells to NK cell cytolysis. These results suggest that the combined effect of methyl gallate, oxaliplatin and NK cells in ovarian cancer cells warrants further investigation, for example for refractory ovarian cancer. Our work is a step towards better scientific understanding of the traditional anticancer use of L. indica."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore. phansy@nus.edu.sg."}], "LastName": "Neo", "ForeName": "Soek-Ying", "Initials": "SY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Siew", "ForeName": "Yin-Yin", "Initials": "YY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Yew", "ForeName": "Hui-Chuing", "Initials": "HC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "He", "ForeName": "Yaqian", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Poh", "ForeName": "Keng-Ling", "Initials": "KL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Tsai", "ForeName": "Yi-Chen", "Initials": "YC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Ng", "ForeName": "Shu-Ling", "Initials": "SL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Tan", "ForeName": "Wei-Xun", "Initials": "WX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Chong", "ForeName": "Teck-Ian", "Initials": "TI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Lim", "ForeName": "Claire Sophie En-Shen", "Initials": "CSE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Ho", "ForeName": "Samuel Shan-Wei", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore."}], "LastName": "Singh", "ForeName": "Deepika", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Science Institute of Singapore, 14 Medical Drive, Singapore, 117599, Singapore."}], "LastName": "Ali", "ForeName": "Azhar", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Haematology, Singapore General Hospital, 20 College Road, Singapore, 169856, Singapore."}], "LastName": "Linn", "ForeName": "Yeh-Ching", "Initials": "YC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive, Singapore, 117600, Singapore."}], "LastName": "Tan", "ForeName": "Chay-Hoon", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore. seow.see.voon@nccs.com.sg."}], "LastName": "Seow", "ForeName": "See-Voon", "Initials": "SV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore. phakohhl@nus.edu.sg."}], "LastName": "Koh", "ForeName": "Hwee-Ling", "Initials": "HL"}], "GrantList": [{"GrantID": "A-0004622-00-00", "Agency": "Gift donation", "Country": ""}, {"GrantID": "A-0004622-00-00", "Agency": "Gift donation", "Country": ""}, {"GrantID": "A-0004622-00-00", "Agency": "Gift donation", "Country": ""}, {"GrantID": "A-0004622-00-00", "Agency": "Gift donation", "Country": ""}, {"GrantID": "A-0004348-00-00", "Agency": "National University of Singapore research grant", "Country": ""}, {"GrantID": "A-0004348-00-00", "Agency": "National University of Singapore research grant", "Country": ""}, {"GrantID": "A-000-284-500-00", "Agency": "Lee Foundation grant", "Country": ""}, {"GrantID": "A-000-284-500-00", "Agency": "Lee Foundation grant", "Country": ""}, {"GrantID": "A-000-284-500-00", "Agency": "Lee Foundation grant", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "04ZR38536J", "NameOfSubstance": "Oxaliplatin"}, {"RegistryNumber": "623D3XG80C", "NameOfSubstance": "methyl gallate"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oxaliplatin"}, {"QualifierName": [], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Ovarian Neoplasms"}, {"QualifierName": [], "DescriptorName": "Killer Cells, Natural"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. doi: 10.3322/caac.21763.", "ArticleIdList": ["10.3322/caac.21763", "36633525"]}, {"Citation": "Carioli G, Bertuccio P, Boffetta P, Levi F, La Vecchia C, Negri E, Malvezzi M. European cancer mortality predictions for the year 2020 with a focus on prostate cancer. Ann Oncol. 2020;31(5):650\u2013658. doi: 10.1016/j.annonc.2020.02.009.", "ArticleIdList": ["10.1016/j.annonc.2020.02.009", "32321669"]}, {"Citation": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Chandra A, Pius C, Nabeel M, Nair M, Vishwanatha JK, Ahmad S, Basha R. Ovarian cancer: Current status and strategies for improving therapeutic outcomes. CA Cancer J Clin. 2019;8(16):7018\u20137031.", "ArticleIdList": ["PMC6853829", "31560828"]}, {"Citation": "Kurnit KC, Fleming GF, Lengyel E. Updates and new options in advanced epithelial ovarian cancer treatment. Obstet Gynecol. 2021;137(1):108\u2013121. doi: 10.1097/AOG.0000000000004173.", "ArticleIdList": ["10.1097/AOG.0000000000004173", "PMC7737875", "33278287"]}, {"Citation": "Gonz\u00e1lez-Mart\u00edn A, Desauw C, Heitz F, Cropet C, Gargiulo P, Berger R, Ochi H, Vergote I, Colombo N, Mirza MR, Tazi Y, Canzler U, Zamagni C, Guerra-Alia EM, Levach\u00e9 CB, Marm\u00e9 F, Bazan F, de Gregorio N, Dohollou N, Fasching PA, Scambia G, Rubio-P\u00e9rez MJ, Milenkova T, Costan C, Pautier P, Ray-Coquard I, PAOLA1/ENGOT-ov25 investigators Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial. Eur J Cancer. 2022;174:221\u2013231. doi: 10.1016/j.ejca.2022.07.022.", "ArticleIdList": ["10.1016/j.ejca.2022.07.022", "36067615"]}, {"Citation": "Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u2013668. doi: 10.1038/s41577-020-0306-5.", "ArticleIdList": ["10.1038/s41577-020-0306-5", "PMC7238960", "32433532"]}, {"Citation": "Liu S, Galat V, Galat Y, Lee YKA, Wainwright D, Wu J. NK cell-based cancer immunotherapy: from basic biology to clinical development. J Hematol Oncol. 2021;14(1):7. doi: 10.1186/s13045-020-01014-w.", "ArticleIdList": ["10.1186/s13045-020-01014-w", "PMC7788999", "33407739"]}, {"Citation": "Du N, Guo F, Wang Y, Cui J. NK cell therapy: A rising star in cancer treatment. Cancers (Basel) 2021;13(16):4129. doi: 10.3390/cancers13164129.", "ArticleIdList": ["10.3390/cancers13164129", "PMC8394762", "34439285"]}, {"Citation": "Wolf NK, Kissiov DU, Raulet DH. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat Rev Immunol. 2023;23(2):90\u2013105. doi: 10.1038/s41577-022-00732-1.", "ArticleIdList": ["10.1038/s41577-022-00732-1", "35637393"]}, {"Citation": "Anand U, Dey A, Chandel AK, Sanyal R, Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R, Chaudhary A, Dhanjal JK. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2022. 10.1016/j.gendis.2022.02.007."}, {"Citation": "Zhou J, Wang G, Chen Y, Wang H, Hua Y, Cai Z. Immunogenic cell death in cancer therapy: Present and emerging inducers. J Cell Mol Med. 2019;23(8):4854\u20134865. doi: 10.1111/jcmm.14356.", "ArticleIdList": ["10.1111/jcmm.14356", "PMC6653385", "31210425"]}, {"Citation": "Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 2020;11(11):1013. doi: 10.1038/s41419-020-03221-2.", "ArticleIdList": ["10.1038/s41419-020-03221-2", "PMC7691519", "33243969"]}, {"Citation": "Savant SS, Sriramkumar S, O\u2019Hagan HM. The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer. Cancers. 2018;10:251. doi: 10.3390/cancers10080251.", "ArticleIdList": ["10.3390/cancers10080251", "PMC6116184", "30061485"]}, {"Citation": "Behzadi P, Sameer AS, Nissar S, Banday MZ, Gajd\u00e1cs M, Garc\u00eda-Perdomo HA, Akhtar K, Pinheiro M, Magnusson P, Sarshar M, Ambrosi C. The interleukin-1 (IL-1) superfamily cytokines and their single nucleotide polymorphisms (SNPS) J Immunol Res. 2022;2022:2054431. doi: 10.1155/2022/2054431.", "ArticleIdList": ["10.1155/2022/2054431", "PMC8976653", "35378905"]}, {"Citation": "Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770\u2013803. doi: 10.1021/acs.jnatprod.9b01285.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Bais S. A phytopharmacological review on an important medicinal plant: Leea indica. Inven Rapid Ethnopharmacol. 2013;2013(1):1\u20134."}, {"Citation": "Singh S, Siew YY, Yew HC, Neo SY, Koh HL. Botany, Phytochemistry and Pharmacological activities of Leea Species. In: Patra KJK, Rudramurthy GR, editors. Medicinal Plants: Chemistry, Pharmacology, and Therapeutic Applications. Boca Raton, Florida: CRC Press; 2019. p. 12."}, {"Citation": "Lok AFS, Ang W, Ng BYQ, Suen SM, Yeo CK, Tan HTW. Leea L. (Vitaceae) of Singapore. Nat Singap. 2011;4(1):55\u201371."}, {"Citation": "Burkill IH. A dictionary of the economic products of the Malay Peninsula. 2. London, England: Crown Agents; 1966."}, {"Citation": "Siew YY, Zareisedehizadeh S, Seetoh WG, Neo SY, Tan CH, Koh HL. Ethnobotanical survey of usage of fresh medicinal plants in Singapore. J Ethnopharmacol. 2014;155(3):1450\u20131466. doi: 10.1016/j.jep.2014.07.024.", "ArticleIdList": ["10.1016/j.jep.2014.07.024", "25058874"]}, {"Citation": "Dalu D, Duggirala S, Akarapu S. Antihyperglycemic and hypolipidemic activity of Leea indica. International Journal of Bioassays. 2014;3(7):3155\u20133159."}, {"Citation": "Rahman MA, Imran TB, Islam S. Antioxidative, antimicrobial and cytotoxic effects of the phenolics of Leea indica leaf extract. Saudi J Biol Sci. 2013;20(3):213\u2013225. doi: 10.1016/j.sjbs.2012.11.007.", "ArticleIdList": ["10.1016/j.sjbs.2012.11.007", "PMC3730544", "23961238"]}, {"Citation": "Yau Hsiung W, Abdul KH. Leea indica ethyl acetate fraction induces growth-inhibitory effect in various cancer cell lines and apoptosis in Ca Ski human cervical epidermoid carcinoma cells. Evid Based Complement Alternat Med. 2011;2011:293060. doi: 10.1155/2011/293060.", "ArticleIdList": ["10.1155/2011/293060", "PMC3057472", "21423690"]}, {"Citation": "Raihan MO, Habib MR, Brishti A, Rahman MM, Saleheen MM, Manna M. Sedative and anxiolytic effects of the methanolic extract of Leea indica (Burm. f.) Merr. Leaf. Leaf Drug Discov Ther. 2011;5(4):185\u2013189. doi: 10.5582/ddt.2011.v5.4.185.", "ArticleIdList": ["10.5582/ddt.2011.v5.4.185", "22466299"]}, {"Citation": "Rahman MA, Sultana R, Bin Emran T, Islam MS, Rahman MA, Chakma JS, Rashid HU, Hasan CM. Effects of organic extracts of six Bangladeshi plants on in vitro thrombolysis and cytotoxicity. BMC Complement Altern Med. 2013;13:25. doi: 10.1186/1472-6882-13-25.", "ArticleIdList": ["10.1186/1472-6882-13-25", "PMC3567938", "23363538"]}, {"Citation": "Temkitthawon P, Viyoch J, Limpeanchob N, Pongamornkul W, Sirikul C, Kumpila A, Suwanborirux K, Ingkaninan K. Screening for phosphodiesterase inhibitory activity of Thai medicinal plants. J Ethnopharmacol. 2008;119(2):214\u2013217. doi: 10.1016/j.jep.2008.05.034.", "ArticleIdList": ["10.1016/j.jep.2008.05.034", "18582551"]}, {"Citation": "Srinivasan GV, Sharanappa P, Leela NK, Sadashiva CT, Vijayan KK. Chemical composition and antimicrobial activity of the essential oil of Leea indica (Burm. f.) Merr. flowers. Nat Prod Rad. 2009;8(5):488\u2013493."}, {"Citation": "Saha K, Lajis NH, Israf DA, Hamzah AS, Khozirah S, Khamis S, Syahida A. Evaluation of antioxidant and nitric oxide inhibitory activities of selected Malaysian medicinal plants. J Ethnopharmacol. 2004;92(2\u20133):263\u2013267. doi: 10.1016/j.jep.2004.03.007.", "ArticleIdList": ["10.1016/j.jep.2004.03.007", "15138010"]}, {"Citation": "Siew YY, Yew HC, Neo SY, Seow SV, Lew SM, Lim SW, Lim CSE, Ng YC, Seetoh WG, Ali A, Tan CH, Koh HL. Evaluation of anti-proliferative activity of medicinal plants used in Asian Traditional Medicine to treat cancer. J Ethnopharmacol. 2019;235:75\u201387. doi: 10.1016/j.jep.2018.12.040.", "ArticleIdList": ["10.1016/j.jep.2018.12.040", "30599223"]}, {"Citation": "The World Flora Online . Leea indica (Burm.f.) Merr. 2022."}, {"Citation": "Singh D, Siew YY, Chong TI, Yew HC, Ho SS, Lim CSE, Tan WX, Neo SY, Koh HL. Identification of phytoconstituents in Leea indica (Burm. F.) Merr. leaves by high performance liquid chromatography micro time-of-flight mass spectrometry. Molecules. 2019;24(4):714. doi: 10.3390/molecules24040714.", "ArticleIdList": ["10.3390/molecules24040714", "PMC6412998", "30781458"]}, {"Citation": "Wee HN, Neo SY, Singh D, Yew HC, Qiu ZY, Tsai XC, How SY, Yip KC, Tan CH, Koh HL. Effects of Vitex trifolia L. leaf extracts and phytoconstituents on cytokine production in human U937 macrophages. BMC Complement Med Ther. 2020;20(1):91. doi: 10.1186/s12906-020-02884-w.", "ArticleIdList": ["10.1186/s12906-020-02884-w", "PMC7081688", "32188443"]}, {"Citation": "Fujisaki H, Kakuda H, Shimasaki N, Imai C, Ma J, Lockey T, Eldridge P, Leung WH, Campana D. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. Cancer Res. 2009;69(9):4010\u20134017. doi: 10.1158/0008-5472.CAN-08-3712.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-3712", "PMC2716664", "19383914"]}, {"Citation": "Cho D, Shook DR, Shimasaki N, Chang YH, Fujisaki H, Campana D. Cytotoxicity of activated natural killer cells against pediatric solid tumors Clin Cancer Res. 2010;16(15):3901\u20133909.", "ArticleIdList": ["PMC3168562", "20542985"]}, {"Citation": "Siew YY, Neo SY, Yew HC, Lim SW, Ng YC, Lew SM, Seetoh WG, Seow SV, Koh HL. Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity. Int Immunol. 2015;27(12):621\u2013632. doi: 10.1093/intimm/dxv041.", "ArticleIdList": ["10.1093/intimm/dxv041", "26138671"]}, {"Citation": "Jondeau A, Dahbi L, Bani-Estivals MH, Chagnon MC. Evaluation of the sensitivity of three sublethal cytotoxicity assays in human HepG2 cell line using water contaminants. Toxicology. 2006;226(2\u20133):218\u2013228. doi: 10.1016/j.tox.2006.07.007.", "ArticleIdList": ["10.1016/j.tox.2006.07.007", "16930799"]}, {"Citation": "Dourlat J, Liu WQ, Gresh N, Garbay C. Novel 1,4-benzodiazepine derivatives with antiproliferative properties on tumor cell lines. Bioorg Med Chem Lett. 2007;17(9):2527\u20132530. doi: 10.1016/j.bmcl.2007.02.016.", "ArticleIdList": ["10.1016/j.bmcl.2007.02.016", "17317183"]}, {"Citation": "Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, Aymeric L, Michaud M, Apetoh L, Barault L, Mendiboure J, Pignon JP, Jooste V, van Endert P, Ducreux M, Zitvogel L, Piard F, Kroemer G. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 2010;29(4):482\u2013491. doi: 10.1038/onc.2009.356.", "ArticleIdList": ["10.1038/onc.2009.356", "19881547"]}, {"Citation": "Alcindor T, Beauger N. Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol. 2011;18(1):18\u201325. doi: 10.3747/co.v18i1.708.", "ArticleIdList": ["10.3747/co.v18i1.708", "PMC3031353", "21331278"]}, {"Citation": "Gebremedhn EG, Shortland PJ, Mahns DA. The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review. BMC Cancer. 2018;18(1):410. doi: 10.1186/s12885-018-4185-0.", "ArticleIdList": ["10.1186/s12885-018-4185-0", "PMC5897924", "29649985"]}, {"Citation": "Yu Z, Huang R, Zhao L, Wang X, Shangguan X, Li W, Li M, Yin X, Zhang C, Liu D. Safety profile of oxaliplatin in 3,687 patients with cancer in China: A post-marketing surveillance study. Front Oncol. 2021;11:757196. doi: 10.3389/fonc.2021.757196.", "ArticleIdList": ["10.3389/fonc.2021.757196", "PMC8567037", "34745993"]}, {"Citation": "Saralamp P. Medicinal Plants in Thailand. Bangkok, Thailand: Department of Pharmaceutical Botany Faculty of Pharmacy, Mahidol University; 1997."}, {"Citation": "Wong YH, Abdul Kadir H, Ling SK. Bioassay-guided isolation of cytotoxic cycloartane triterpenoid glycosides from the traditionally used medicinal plant Leea indica. Evid Based Complement Alternat Med. 2012;2012:164689. doi: 10.1155/2012/164689.", "ArticleIdList": ["10.1155/2012/164689", "PMC3235747", "22203865"]}, {"Citation": "Wong YH, Abdul KH. Induction of mitochondria-mediated apoptosis in Ca Ski human cervical cancer cells triggered by mollic acid arabinoside isolated from Leea indica. Evid Based Complement Alternat Med. 2012;2012:684740. doi: 10.1155/2012/684740.", "ArticleIdList": ["10.1155/2012/684740", "PMC3236607", "22203877"]}, {"Citation": "Huntington ND, Cursons J, Rautela J. The cancer-natural killer cell immunity cycle. Nat Rev Cancer. 2020;20(8):437\u2013454. doi: 10.1038/s41568-020-0272-z.", "ArticleIdList": ["10.1038/s41568-020-0272-z", "32581320"]}, {"Citation": "Shimasaki N, Jain A, Campana D. NK cells for cancer immunotherapy. Nat Rev Drug Discov. 2020;19(3):200\u2013218. doi: 10.1038/s41573-019-0052-1.", "ArticleIdList": ["10.1038/s41573-019-0052-1", "31907401"]}, {"Citation": "Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A, Salih HR. Soluble MICA in malignant diseases. Int J Cancer. 2006;118(3):684\u2013687. doi: 10.1002/ijc.21382.", "ArticleIdList": ["10.1002/ijc.21382", "16094621"]}, {"Citation": "Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, Plymate SR. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest. 2004;114(4):560\u2013568. doi: 10.1172/JCI200422206.", "ArticleIdList": ["10.1172/JCI200422206", "PMC503776", "15314693"]}, {"Citation": "Armeanu S, Krusch M, Baltz KM, Weiss TS, Smirnow I, Steinle A, Lauer UM, Bitzer M, Salih HR. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma. Clin Cancer Res. 2008;14(11):3520\u20133528. doi: 10.1158/1078-0432.CCR-07-4744.", "ArticleIdList": ["10.1158/1078-0432.CCR-07-4744", "18519785"]}, {"Citation": "Wennerberg E, Sarhan D, Carlsten M, Kaminskyy VO, D'Arcy P, Zhivotovsky B, Childs R, Lundqvist A. Doxorubicin sensitizes human tumor cells to NK and T cell-mediated killing by augmented TRAIL-receptor signalling. Int J Cancer. 2013;133(7):1643\u20131652. doi: 10.1002/ijc.28163.", "ArticleIdList": ["10.1002/ijc.28163", "PMC8725935", "23504627"]}, {"Citation": "Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, Michaud M, Menger L, Gdoura A, Tajeddine N, Tesniere A, Zitvogel L, Kroemer G. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene. 2011;30(10):1147\u20131158. doi: 10.1038/onc.2010.500.", "ArticleIdList": ["10.1038/onc.2010.500", "21151176"]}, {"Citation": "Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di Gialleonardo V, Cippitelli M, Fionda C, Petrucci MT, Guarini A, Fo\u00e0 R, Santoni A. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood. 2009;113(15):3503\u20133511. doi: 10.1182/blood-2008-08-173914.", "ArticleIdList": ["10.1182/blood-2008-08-173914", "19098271"]}, {"Citation": "Sansone C, Bruno A, Piscitelli C, Baci D, Fontana A, Brunet C, Noonan DM, Albini A. Natural compounds of marine origin as inducers of immunogenic cell death (ICD): potential role for cancer interception and therapy. Cells. 2021;10(2):231. doi: 10.3390/cells10020231.", "ArticleIdList": ["10.3390/cells10020231", "PMC7912082", "33504012"]}, {"Citation": "Leischner C, Burkard M, Pfeiffer MM, Lauer UM, Busch C, Venturelli S. Nutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatment. Nutr J. 2016;15(1):47. doi: 10.1186/s12937-016-0167-8.", "ArticleIdList": ["10.1186/s12937-016-0167-8", "PMC4855330", "27142426"]}, {"Citation": "Yao B, Yang Q, Yang Y, Li Y, Peng H, Wu S, Wang L, Zhang S, Huang M, Wang E, Xiong P, Luo T, Li L, Jia S, Deng Y, Deng Y. Screening for active compounds targeting human natural killer cell activation identifying daphnetin as an enhancer for IFN-g production and direct cytotoxicity. Front Immunol. 2021;12:680611. doi: 10.3389/fimmu.2021.680611.", "ArticleIdList": ["10.3389/fimmu.2021.680611", "PMC8693168", "34956168"]}, {"Citation": "Ji S, Lee JY, Schr\u00f6r J, Mazumder A, Jang DM, Chateauvieux S, Schnekenburger M, Hong CR, Christov C, Kang HJ, Lee Y, Han BW, Kim KW, Shin HY, Dicato M, Cerella C, K\u00f6nig GM, Orlikova B, Diederich M. The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancer. Cancer Lett. 2018;416:109\u2013123. doi: 10.1016/j.canlet.2017.12.011.", "ArticleIdList": ["10.1016/j.canlet.2017.12.011", "29246646"]}, {"Citation": "Hu L, Cao D, Li Y, He Y, Guo K. Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors. Cancer Biol Ther. 2012;13(7):516\u2013526. doi: 10.4161/cbt.19601.", "ArticleIdList": ["10.4161/cbt.19601", "22406996"]}, {"Citation": "Lee Y, Shin H, Kim J. In vivo anti-cancer effects of resveratrol mediated by NK cell activation. J Innate Immun. 2021;13(2):94\u2013106. doi: 10.1159/000510315.", "ArticleIdList": ["10.1159/000510315", "PMC8077674", "32937636"]}, {"Citation": "Wang D, Zhu B, Liu X, Han Q, Ge W, Zhang W, Lu Y, Wu Q, Shi L. Daphnetin ameliorates experimental autoimmune encephalomyelitis through regulating heme oxygenase-1. Neurochem Res. 2020;45(4):872\u2013881. doi: 10.1007/s11064-020-02960-0.", "ArticleIdList": ["10.1007/s11064-020-02960-0", "31950453"]}, {"Citation": "Dedoussis GV, Kaliora AC, Andrikopoulos NK. Effect of phenols on natural killer (NK) cell-mediated death in the K562 human leukemic cell line. Cell Biol Int. 2005;29(11):884\u2013889. doi: 10.1016/j.cellbi.2005.07.006.", "ArticleIdList": ["10.1016/j.cellbi.2005.07.006", "16198604"]}, {"Citation": "Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, Han J, Wei X. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target Ther. 2019;4:62. doi: 10.1038/s41392-019-0095-0.", "ArticleIdList": ["10.1038/s41392-019-0095-0", "PMC6915746", "31871779"]}, {"Citation": "Abou-Zaid MM, Lombardo DA, Nozzolillo C. Methyl gallate is a natural constituent of maple (Genus Acer) leaves. Nat Product Res. 2009;23(15):1373\u20131377. doi: 10.1080/14786410802420457.", "ArticleIdList": ["10.1080/14786410802420457", "19809908"]}, {"Citation": "Park DJ, Jung HJ, Park CH, Yokozawa T, Jeong JC. Root bark of Paeonia suffruticosa extract and its component methyl gallate possess peroxynitrite scavenging activity and anti-inflammatory properties through NF-kappaB inhibition in LPS-treated mice. Molecules. 2019;24(19):3483. doi: 10.3390/molecules24193483.", "ArticleIdList": ["10.3390/molecules24193483", "PMC6804175", "31557976"]}, {"Citation": "Rosas EC, Correa LB, P\u00e1dua Tde A, Costa TE, Mazzei JL, Heringer AP, Bizarro CA, Kaplan MA, Figueiredo MR, Henriques MG. Anti-inflammatory effect of Schinus terebinthifolius Raddi hydroalcoholic extract on neutrophil migration in zymosan-induced arthritis. J Ethnopharmacol. 2015;175:490\u2013498. doi: 10.1016/j.jep.2015.10.014.", "ArticleIdList": ["10.1016/j.jep.2015.10.014", "26453933"]}, {"Citation": "Cho EJ, Yokozawa T, Kim HY, Shibahara N, Park JC. Rosa rugosa attenuates diabetic oxidative stress in rats with streptozotocin-induced diabetes. Am J Chin Med. 2004;32(4):487\u2013496. doi: 10.1142/S0192415X04002132.", "ArticleIdList": ["10.1142/S0192415X04002132", "15481639"]}, {"Citation": "Choi JG, Mun SH, Chahar HS, Bharaj P, Kang OH, Kim SG, Shin DW, Kwon DY. Methyl gallate from Galla rhois successfully controls clinical isolates of Salmonella infection in both in vitro and in vivo systems. PLoS ONE. 2014;9(7):e102697. doi: 10.1371/journal.pone.0102697.", "ArticleIdList": ["10.1371/journal.pone.0102697", "PMC4105534", "25048362"]}, {"Citation": "Rahman N, Jeon M, Kim YS. Methyl gallate, a potent antioxidant inhibits mouse and human adipocyte differentiation and oxidative stress in adipocytes through impairment of mitotic clonal expansion. BioFactors. 2016;42(6):716\u2013726. doi: 10.1002/biof.1310.", "ArticleIdList": ["10.1002/biof.1310", "27412172"]}, {"Citation": "Choi JG, Kang OH, Lee YS, Oh YC, Chae HS, Jang HJ, Shin DW, Kwon DY. Antibacterial activity of methyl gallate isolated from Galla Rhois or carvacrol combined with nalidixic acid against nalidixic acid resistant bacteria. Molecules. 2009;14(5):1773\u20131780. doi: 10.3390/molecules14051773.", "ArticleIdList": ["10.3390/molecules14051773", "PMC6254153", "19471197"]}, {"Citation": "Huang CY, Chang YJ, Wei PL, Hung CS, Wang W. Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells. PLoS ONE. 2021;16(3):e0248521. doi: 10.1371/journal.pone.0248521.", "ArticleIdList": ["10.1371/journal.pone.0248521", "PMC7963062", "33725002"]}, {"Citation": "Correa LB, P\u00e1dua TA, Seito LN, Costa TE, Silva MA, Cand\u00e9a AL, Rosas EC, Henriques MG. Henriques, Anti-inflammatory effect of methyl gallate on experimental arthritis: inhibition of neutrophil recruitment, production of inflammatory mediators, and activation of macrophages. J Nat Prod. 2016;79(6):1554\u20131566. doi: 10.1021/acs.jnatprod.5b01115.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01115", "27227459"]}, {"Citation": "Correa LB, Seito LN, Manchope MF, Verri WA, Jr, Cunha TM, Henriques MG, Rosas EC. Methyl gallate attenuates inflammation induced by Toll-like receptor ligands by inhibiting MAPK and NF-\u039ab signaling pathways. Inflamm Res. 2020;69(12):1257\u20131270. doi: 10.1007/s00011-020-01407-0.", "ArticleIdList": ["10.1007/s00011-020-01407-0", "33037469"]}, {"Citation": "Chae HS, Kang OH, Choi JG, Oh YC, Lee YS, Brice OO, Chong MS, Lee KN, Shin DW, Kwon DY. Methyl gallate inhibits the production of interleukin-6 and nitric oxide via down-regulation of extracellular-signal regulated protein kinase in RAW 264.7 cells. Am J Chin Med. 2010;38(5):973\u2013983. doi: 10.1142/S0192415X10008391.", "ArticleIdList": ["10.1142/S0192415X10008391", "20821827"]}, {"Citation": "Ortiz M, Wabel E, Mitchell K, Horibata S. Mechanisms of chemotherapy resistance in ovarian cancer. Cancer Drug Resist. 2022;5(2):304\u2013316.", "ArticleIdList": ["PMC9255249", "35800369"]}, {"Citation": "Zhang C, Xu C, Gao X, Yao Q. Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics. 2022;12(5):2115\u20132132. doi: 10.7150/thno.69424.", "ArticleIdList": ["10.7150/thno.69424", "PMC8899578", "35265202"]}, {"Citation": "Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Oxaliplatin for the treatment of ovarian cancer. Expert Opin Investig Drugs. 2015;24(9):1275\u20131286. doi: 10.1517/13543784.2015.1062874.", "ArticleIdList": ["10.1517/13543784.2015.1062874", "26125301"]}, {"Citation": "Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255\u20132273. doi: 10.1056/NEJMra2026131.", "ArticleIdList": ["10.1056/NEJMra2026131", "PMC7727315", "33264547"]}, {"Citation": "Horikawa N, Abiko K, Matsumura N, Hamanishi J, Baba T, Yamaguchi K, Yoshioka Y, Koshiyama M, Konishi I. Expression of vascular endothelial growth factor in ovarian cancer inhibits tumor immunity through the accumulation of myeloid-derived suppressor cells. Clin Cancer Res. 2017;23(2):587\u2013599. doi: 10.1158/1078-0432.CCR-16-0387.", "ArticleIdList": ["10.1158/1078-0432.CCR-16-0387", "27401249"]}, {"Citation": "Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 2005;102(51):18538\u201318543. doi: 10.1073/pnas.0509182102.", "ArticleIdList": ["10.1073/pnas.0509182102", "PMC1311741", "16344461"]}, {"Citation": "Bai J, Zhang Y, Tang C, Hou Y, Ai X, Chen X, Zhang Y, Wang X, Meng X. Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomed Pharmacother. 2021;133:110985. doi: 10.1016/j.biopha.2020.110985.", "ArticleIdList": ["10.1016/j.biopha.2020.110985", "33212373"]}, {"Citation": "Lin Y, Luo T, Weng A, Huang X, Yao Y, Fu Z, Li Y, Liu A, Li X, Chen D, Pan H. Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Front Immunol. 2020;11:580593. doi: 10.3389/fimmu.2020.580593.", "ArticleIdList": ["10.3389/fimmu.2020.580593", "PMC7750458", "33365024"]}, {"Citation": "Piura B, Medina L, Rabinovich A, Dyomin V, Levy RS, Huleihel M. Distinct expression and localization of TNF system in ovarian carcinoma tissues: possible involvement of TNF-\u03b1 in morphological changes of ovarian cancerous cells. Anticancer Res. 2014;34(2):745\u2013752.", "ArticleIdList": ["24511008"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "17"}, {"Year": "2023", "Month": "3", "Day": "1"}, {"Year": "2023", "Month": "3", "Day": "10", "Hour": "23", "Minute": "36"}, {"Year": "2023", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["36899361", "PMC10007844", "10.1186/s12906-023-03904-1", "10.1186/s12906-023-03904-1"]}}], "PubmedBookArticle": []}